voriconazole has been researched along with Co-infection in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 8 (42.11) | 2.80 |
| Authors | Studies |
|---|---|
| Marsh, JJ; Sabino, R; Sass, G; Shrestha, P; Stevens, DA | 1 |
| Huang, Y; Xu, Y; Zhang, Y | 1 |
| Kakizaki, H; Sarbajna, T; Takahashi, Y; Vaidya, A | 1 |
| Akata, K; Fukuda, K; Fukuda, Y; Ikegami, H; Ikushima, I; Kawanami, T; Nakamura, M; Noguchi, S; Yamasaki, K; Yatera, K | 1 |
| Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS | 1 |
| Bassetti, M; Böll, B; Brüggemann, R; Chakrabarti, A; Chen, SCA; Colombo, AL; Cornely, OA; Gangneux, JP; Hoenigl, M; Klimko, N; Koehler, P; Lass-Flörl, C; Meis, JF; Oladele, RO; Ostrosky-Zeichner, L; Patterson, TF; Perfect, JR; Persigehl, T; Verweij, PE; Vinh, DC; White, PL; Zhu, LP | 1 |
| Deokar, K; Goel, R; Jain, A; Shadrach, BJ | 1 |
| Ai, L; Chen, Y; Huang, J; Liang, Y; Tang, W; Zhao, Y; Zhou, Y | 1 |
| Kim, SH; Park, SY; Yoon, JA | 1 |
| Anract, P; Archambeau, D; Epelboin, L; Eyrolle, L; Gaume, M; Gauzit, R; Larousserie, F; Lavielle, M; Leclerc, P; Lortholary, O; Marie-Hardy, L; Paugam, A; Roux, C; Salmon, D | 1 |
| Boongird, A; Chongtrakool, P; Jirasiritham, S; Larbcharoensub, N; Sumethkul, V; Watcharananan, SP; Wirojtananugoon, C | 1 |
| Eguchi, H; Hayashi, Y; Mitamura, Y; Toibana, T; Yaguchi, T | 1 |
| Kong, QT; Liu, F; Liu, HB; Liu, WD; Lv, GX; Sang, H; Shen, YN | 1 |
| Alcazar-Fuoli, L; Buitrago, M; Gomez-Lopez, A; Mellado, E | 1 |
| Beitz, A; Ehmer, U; Eser, S; Fekecs, L; Huber, W; Lahmer, T; Messer, M; Schmid, RM | 1 |
| Hishiki, H; Ishiwada, N; Kamei, K; Nagasawa, K; Shimojo, N; Takeshita, K; Takeuchi, N; Watanabe, A; Yaguchi, T | 1 |
| de Sévaux, RG; Kolwijck, E; Melchers, WJ; Rijstenberg, LL; ten Oever, J; van der Hoeven, H; van der Lee, HA; Verweij, PE; Zoll, J | 1 |
| Akyol, G; Atalay, A; Cakir, N; Kaynar, L; Koc, AN; Ulu-Kilic, A | 1 |
| Figiel, W; Krawczyk, M; Sulik-Tyszka, B; Wróblewska, M | 1 |
4 review(s) available for voriconazole and Co-infection
| Article | Year |
|---|---|
Pulmonary Mycobacterium parascrofulaceum Infection in a Patient with Chronic Progressive Pulmonary Aspergillosis: A Case Report and Literature Review.
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Chronic Disease; Coinfection; Female; Humans; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Pulmonary Aspergillosis; Treatment Outcome; Voriconazole | 2020 |
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.
Topics: Amphotericin B; Antifungal Agents; Azoles; Coinfection; COVID-19; Humans; Nitriles; Pulmonary Aspergillosis; Pyridines; SARS-CoV-2; Triazoles; Voriconazole | 2021 |
Voriconazole-refractory invasive aspergillosis.
Topics: Antifungal Agents; Aspergillus; Biopsy; Coinfection; Cytochrome P-450 CYP2C19; Diagnosis, Differential; Diagnostic Errors; Drug Monitoring; Drug Resistance, Fungal; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pharmacogenetics; Pharmacogenomic Variants; Predictive Value of Tests; Tomography, X-Ray Computed; Voriconazole | 2017 |
Successful Treatment of Refractory Majocchi's Granuloma with Voriconazole and Review of Published Literature.
Topics: Anti-Bacterial Agents; Antifungal Agents; Ceftizoxime; Coinfection; Granuloma; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Middle Aged; Tinea; Treatment Outcome; Trichophyton; Voriconazole | 2015 |
15 other study(ies) available for voriconazole and Co-infection
| Article | Year |
|---|---|
Synergy Between
Topics: Aspergillus fumigatus; Biofilms; Coinfection; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Voriconazole | 2022 |
Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bunyaviridae Infections; Coinfection; Humans; Microbiota; Minocycline; Phlebovirus; Piperacillin; Pneumonia; Retrospective Studies; Severe Fever with Thrombocytopenia Syndrome; Tazobactam; Voriconazole | 2022 |
Topics: Administration, Ophthalmic; Administration, Oral; Adult; Aspergillosis; Aspergillus; Ciprofloxacin; Coinfection; Conjunctiva; Corynebacterium; Corynebacterium Infections; Dacryocystorhinostomy; Drug Therapy, Combination; Female; Humans; Intubation; Lacrimal Duct Obstruction; Levofloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Prostheses and Implants; Retrospective Studies; Slit Lamp Microscopy; Voriconazole | 2020 |
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse.
Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole | 2020 |
Invasive pulmonary aspergillosis in a COVID-19 recovered patient: unravelling an infective sequalae of the SARS-CoV-2 virus.
Topics: Antifungal Agents; Coinfection; COVID-19; Critical Care; Female; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Obesity, Morbid; SARS-CoV-2; Treatment Outcome; Voriconazole | 2021 |
Rapid and precise diagnosis of pneumonia coinfected by Pneumocystis jirovecii and Aspergillus fumigatus assisted by next-generation sequencing in a patient with systemic lupus erythematosus: a case report.
Topics: Adolescent; Aspergillus fumigatus; Caspofungin; Coinfection; Female; High-Throughput Nucleotide Sequencing; Humans; Lupus Erythematosus, Systemic; Opportunistic Infections; Pneumocystis carinii; Pneumonia; Sulfamethoxazole; Trimethoprim; Voriconazole | 2021 |
[Histoplasma capsulatum bone and joint infection].
Topics: Aged; Antibodies, Monoclonal, Humanized; Antifungal Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Aspergillosis; Cervical Vertebrae; Coinfection; Female; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Itraconazole; Knee Joint; Osteitis; Spinal Cord Compression; Voriconazole | 2017 |
Treatment of a brain abscess caused by Scedosporium apiospermum and Phaeoacremonium parasiticum in a renal transplant recipient.
Topics: Antifungal Agents; Brain Abscess; Cerebral Phaeohyphomycosis; Coinfection; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2013 |
Polymicrobial sclerokeratitis caused by Scedosporium apiospermum and Aspergillus cibarius.
Topics: Aged; Antifungal Agents; Aspergillus; Caspofungin; Coinfection; Drug Therapy, Combination; Echinocandins; Eye Infections, Fungal; Female; Humans; Keratitis; Lipopeptides; Scedosporium; Scleritis; Voriconazole | 2014 |
An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Coinfection; Disease Models, Animal; Drug Resistance, Fungal; Humans; Mice; Microbial Sensitivity Tests; Moths; Real-Time Polymerase Chain Reaction; Voriconazole | 2015 |
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; beta-Glucans; Clarithromycin; Coinfection; Critical Illness; Extracorporeal Membrane Oxygenation; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Linezolid; Male; Mannans; Meropenem; Pneumonia; Pseudallescheria; Severe Acute Respiratory Syndrome; Thienamycins; Transplant Recipients; Voriconazole | 2016 |
The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease.
Topics: Adolescent; Antifungal Agents; Ascomycota; Coinfection; Echinocandins; Emericella; Granulomatous Disease, Chronic; Humans; Immunocompromised Host; Lipopeptides; Male; Micafungin; Mycoses; Sputum; Voriconazole | 2016 |
Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Coinfection; Drug Resistance, Fungal; Fatal Outcome; Female; Humans; Male; Middle Aged; Voriconazole | 2016 |
Pulmonary infection caused by Talaromyces purpurogenus in a patient with multiple myeloma.
Topics: Acinetobacter Infections; Aged; Antifungal Agents; Coinfection; Fatal Outcome; Female; Humans; Immunocompromised Host; Lung Diseases, Fungal; Multiple Myeloma; Opportunistic Infections; Plasmacytoma; Pulmonary Disease, Chronic Obstructive; Species Specificity; Spinal Neoplasms; Sputum; Talaromyces; Thoracic Vertebrae; Voriconazole | 2016 |
Invasive Aspergillosis of the Stomach and Co-infection With Candida krusei in a Patient With Terminal Liver Failure: A Case Report.
Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Coinfection; Echinocandins; End Stage Liver Disease; Gastric Mucosa; Humans; Lipopeptides; Liver Transplantation; Stomach Diseases; Voriconazole | 2016 |